Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Psoriasis and TNFRSF1A[original query] |
|---|
| TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012 Aug 488 (7412): 508-11. Gregory Adam P, Dendrou Calliope A, Attfield Kathrine E, Haghikia Aiden, Xifara Dionysia K, Butter Falk, Poschmann Gereon, Kaur Gurman, Lambert Lydia, Leach Oliver A, Prömel Simone, Punwani Divya, Felce James H, Davis Simon J, Gold Ralf, Nielsen Finn C, Siegel Richard M, Mann Matthias, Bell John I, McVean Gil, Fugger La |
| The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients. Archives of dermatological research 2015 Jul 307 (5): 405-12. González-Lara Leire, Batalla Ana, Coto Eliecer, Gómez Juan, Eiris Noemí, Santos-Juanes Jorge, Queiro Rubén, Coto-Segura Pab |
| The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis. International immunopharmacology 2015 Sep 28 (1): 146-53. Chen Wenjuan, Xu Hui, Wang Xiuxiu, Gu Junying, Xiong Huizi, Shi Yuli |
| Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine. International journal of molecular sciences 2023 6 24 (12): . Emilio Berna-Rico, Javier Perez-Bootello, Carlota Abbad-Jaime de Aragon, Alvaro Gonzalez-Cante |
- Page last reviewed:Feb 1, 2024
- Content source: